Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 ...

The central feature of its response to the latest protests has been the Iranian regime’s internet blackout. It’s a portent of ...

Abstract: Recent advances in deep learning-based signal re-representation methods have achieved significant breakthroughs in tasks like signal modulation recognition. In this paper, we propose a ...

The show is over for Pulmocide’s phase 3 trial after patients who received its investigational inhaled antifungal had lower response rates and a higher number of deaths than those in the control arm.

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease ...

No advanced therapies approved to treat ColdU and SD—diseases of misery that dramatically impact all aspects of patient life Barzolvolimab is the only drug in development to demonstrate clinical ...

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) released topline data on Wednesday from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with ...

America’s overdose crisis isn’t the simple story we’ve been told for years. A new investigation reveals how two key graphs — one famous, one ignored — shift entirely the way we understand what ...

Hamas released hostages and agreed to abide by a cease-fire, but persuading it to lay down its arms is another matter. By David M. Halbfinger and Adam Rasgon Reporting from Jerusalem and Tel Aviv ...